 The study concluded that plasma bioavailabilities were extremely low (2.8% and 3.1%, respectively.Additionally, plasma concentrations of tocopherol were not significantly different in patients.This study provides new insight in Vitamin E supplementation and suggest further research is needed with different forms of Vitamin E as possible treatment options to Abetalipoproteinemia.